MAGEA3 and melanoma: The teams of both Van Den Beng and Linette found fatal cardiotoxicity when they used TCR-T cells targeting MART-1 and MAGE-A3 to treat melanoma, which may be related to the high expression of MART-1 and MAGE-A3 in heart tissue [93, 94].